Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

NIAID reports results from phase I trial of anti-HIV antibody VRC-01

Dec. 4, 2015

MPP and University of Liverpool collaborate to develop nanoformulated antiretrovirals

Dec. 2, 2015

Maximal virologic suppression reported at 1 year in phase IIb extension study of PRO-140

Dec. 2, 2015

Mylan outlines plans for antiretroviral treatment TLE-400

Dec. 2, 2015

Shionogi presents anti-HIV agents

Nov. 27, 2015

Gilead Sciences' Genvoya approved in E.U. for HIV-1 infection

Nov. 24, 2015

NIAID and GSK collaborate on broadly neutralizing antibody strategy for HIV infection

Nov. 23, 2015

FDA approves Genvoya single-tablet regimen for HIV-1

Nov. 6, 2015

ViiV Healthcare and Janssen report results from injectable cabotegravir regimen study

Nov. 5, 2015

Bristol-Myers Squibb reports HIV maturation inhibitors

Oct. 27, 2015

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...